Industry News

Industry News

ICIS is partnering with Multiview to produce our email newsletter Signals+ twice a month!

November 2, 2023

The International Cytokine & Interferon Society is pleased to announce that we have partnered with North America’s largest B2B publisher, Multiview, to produce our email newsletter, Signals+. We know how important it is to have direct access to the latest information, trends, and developments in our ever-changing field of practice. [READ MORE]

Industry News

April 19, 2021

By Supreet Agarwal Cytokines represent the major class of all the soluble ligands targeted by FDA-approved drugs  Major cytokines’ (interferons, interleukins and chemokines) targeted therapies Figures adapted from: Attwood, M.M., Jonsson, J., Rask-Andersen, M. et al. Soluble ligands as drug targets.  Nat Rev Drug Discov 19, 695–710 (2020). https://doi.org/10.1038/s41573-020-0078-4 Cytokines based therapies approved in [READ MORE]